EAGLE PHARMACEUTICALS INC (EGRX)
US2697961082 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 187.8M -4.13% | 171.5M -8.68% | 316.6M 84.61% | 263.51M -16.77% | 215.73M -18.13% | 228.48M 5.91% | 320.69M 40.36% | 330.48M 3.05% | |
| EBITDA YoY % growth | 36.54M 38.15% | 6.56M -82.05% | 114.43M 1,644.36% | 82.331M -28.05% | 60.872M -26.06% | 53.04M -12.87% | N/A | N/A | |
| EBIT YoY % growth | 33M 51.38% | 2.8M -91.52% | 102.4M 3,557.14% | 35.598M -65.24% | 11.628M -67.34% | 50.796M 336.84% | 79.356M 56.22% | 80.07M 0.90% | |
| Operating Margin | 17.57% | 1.63% | 32.34% | 13.51% | 5.39% | 22.23% | 24.75% | 24.23% | |
| EPS YoY % growth | 3.54 36.68% | 2.58 -27.12% | 7.82 203.10% | 4.67 -40.26% | 3.34 -28.60% | 3.05 -8.56% | 4.27 40.13% | 4.25 -0.48% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.11 -0.73% | 1.09 -0.78% | 1.00 -20.67% | 0.79 -33.44% | 0.94 -15.60% | 1.04 -4.67% |
| Revenue Q2Q % growth | 64.083M -2.76% | 65.804M 8.41% | 58.854M -11.24% | 56.814M -12.12% | 52.53M -18.03% | 51.51M -21.72% |
| EBITDA Q2Q % growth | 19.733M 6.66% | 19.268M -4.76% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 8.958M -25.97% | 8.492M 3.56% | 11.22M -4.92% | 8.058M -21.77% | 11.832M 32.08% | 17.544M 106.59% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 1.18 -24.36% | 1.07 | 0.11 | 10.18% |
| Q1 2023 Q2Q % growth | 1.26 -68.81% | 1.07 | 0.19 | 17.65% |
| Q4 2022 Q2Q % growth | 1.10 29.41% | 0.85 | 0.25 | 29.93% |
| Q3 2022 Q2Q % growth | 1.12 100.00% | 0.92 | 0.20 | 21.11% |
| Q2 2022 Q2Q % growth | 1.56 67.74% | 3.43 | -1.87 | -54.53% |
| Q1 2022 Q2Q % growth | 4.04 1,583.33% | 3.96 | 0.08 | 1.99% |
| Q4 2021 Q2Q % growth | 0.85 -11.46% | 0.96 | -0.11 | -11.35% |
| Q3 2021 Q2Q % growth | 0.56 -52.14% | 0.85 | -0.29 | -34.12% |
| Q2 2021 Q2Q % growth | 0.93 63.16% | 0.82 | 0.11 | 13.97% |
| Q1 2021 Q2Q % growth | 0.24 -71.43% | 0.66 | -0.42 | -63.80% |
| Q4 2020 Q2Q % growth | 0.96 100.00% | -0.18 | 1.14 | 645.61% |
| Q3 2020 Q2Q % growth | 1.17 350.00% | 0.30 | 0.87 | 288.83% |
| Q2 2020 Q2Q % growth | 0.57 -32.14% | 0.24 | 0.33 | 137.80% |
| Q1 2020 Q2Q % growth | 0.84 -16.83% | 0.58 | 0.26 | 45.12% |
| Q4 2019 Q2Q % growth | 0.48 -60.00% | 0.47 | 0.01 | 1.20% |
| Q3 2019 Q2Q % growth | 0.26 -77.97% | 0.44 | -0.18 | -40.37% |
| Q2 2019 Q2Q % growth | 0.84 -11.58% | 0.84 | 0.00 | -0.48% |
| Q1 2019 Q2Q % growth | 1.01 90.57% | 0.74 | 0.27 | 35.64% |
| Q4 2018 Q2Q % growth | 1.20 | 1.18 | 0.02 | 1.60% |
| Q3 2018 Q2Q % growth | 1.18 | 1.00 | 0.18 | 18.05% |
| Q2 2018 Q2Q % growth | 0.95 | 0.82 | 0.13 | 16.13% |
| Q1 2018 Q2Q % growth | 0.53 | 0.70 | -0.17 | -24.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 64.646M -12.76% | 60.552M | 4.094M | 6.76% |
| Q1 2023 Q2Q % growth | 66.305M -42.79% | 64.553M | 1.752M | 2.71% |
| Q4 2022 Q2Q % growth | 60.7M 43.50% | 65.545M | -4.845M | -7.39% |
| Q3 2022 Q2Q % growth | 65.9M 65.16% | 63.319M | 2.581M | 4.08% |
| Q2 2022 Q2Q % growth | 74.1M 54.05% | 119.22M | -45.12M | -37.85% |
| Q1 2022 Q2Q % growth | 115.9M 181.31% | 125.79M | -9.89M | -7.86% |
| Q4 2021 Q2Q % growth | 42.3M -15.23% | 52.103M | -9.803M | -18.81% |
| Q3 2021 Q2Q % growth | 39.9M -20.04% | 47.328M | -7.428M | -15.69% |
| Q2 2021 Q2Q % growth | 48.1M 14.80% | 46.781M | 1.319M | 2.82% |
| Q1 2021 Q2Q % growth | 41.2M -10.43% | 46.317M | -5.117M | -11.05% |
| Q4 2020 Q2Q % growth | 49.9M 3.31% | 54.225M | -4.325M | -7.98% |
| Q3 2020 Q2Q % growth | 49.9M 21.41% | 47.919M | 1.981M | 4.13% |
| Q2 2020 Q2Q % growth | 41.9M -26.10% | 43.126M | -1.226M | -2.84% |
| Q1 2020 Q2Q % growth | 46M -7.63% | 52.124M | -6.124M | -11.75% |
| Q4 2019 Q2Q % growth | 48.3M -13.90% | 50.057M | -1.757M | -3.51% |
| Q3 2019 Q2Q % growth | 41.1M -19.88% | 46.353M | -5.253M | -11.33% |
| Q2 2019 Q2Q % growth | 56.7M -4.38% | 54.661M | 2.039M | 3.73% |
| Q1 2019 Q2Q % growth | 49.8M 6.87% | 48.012M | 1.788M | 3.72% |
| Q4 2018 Q2Q % growth | 56.1M | 55.257M | 843K | 1.53% |
| Q3 2018 Q2Q % growth | 51.3M | 54.501M | -3.201M | -5.87% |
| Q2 2018 Q2Q % growth | 59.3M | 52.255M | 7.045M | 13.48% |
| Q1 2018 Q2Q % growth | 46.6M | 49.853M | -3.253M | -6.53% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |